Demetri Vassilatis

Title: Demetri Vassilatis: Innovator in G Protein Coupled Receptor Research

Introduction

Demetri Vassilatis is a prominent inventor based in Seattle, WA. He has made significant contributions to the field of biochemistry, particularly in the area of G protein coupled receptors (GPCRs). With a total of 2 patents, his work has implications for the diagnosis and treatment of various diseases.

Latest Patents

Vassilatis's latest patents include innovative research on GPCR polypeptides and polynucleotides. One of his notable inventions is related to G protein coupled receptor 85 and SREB3 knockout mice. This invention provides GPCR polypeptides and polynucleotides, recombinant materials, and transgenic mice, along with methods for their production. These polypeptides and polynucleotides are useful in diagnosing and treating diseases and disorders. Additionally, he has developed methods for identifying compounds, such as agonists or antagonists, that can treat conditions associated with GPCR dysfunction. His work also includes diagnostic assays for detecting diseases linked to inappropriate GPCR activity or levels.

Career Highlights

Demetri Vassilatis is currently associated with Omeros Corporation, where he continues to advance his research in GPCRs. His innovative approach has positioned him as a key figure in the field, contributing to the understanding of GPCR-related diseases.

Collaborations

Throughout his career, Vassilatis has collaborated with notable colleagues, including George A Gaitanaris and John E Bergmann. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Demetri Vassilatis is a distinguished inventor whose work in GPCR research has the potential to transform the landscape of disease diagnosis and treatment. His contributions are invaluable to the scientific community and hold promise for future advancements in healthcare.